BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24618611)

  • 1. Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expression.
    Ohgami RS; Sendamarai AK; Atwater SK; Liedtke M; Fleming MD; Natkunam Y; Warnke RA
    Am J Surg Pathol; 2014 Sep; 38(9):1298-304. PubMed ID: 24618611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.
    Ohgami RS; Arber DA; Zehnder JL; Natkunam Y; Warnke RA
    Adv Anat Pathol; 2013 May; 20(3):137-40. PubMed ID: 23574769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular Dendritic Cell Sarcoma With Indolent T-Lymphoblastic Proliferation Is Associated With Paraneoplastic Autoimmune Multiorgan Syndrome.
    Walters M; Pittelkow MR; Hasserjian RP; Harris NL; Macon WR; Kurtin PJ; Rech KLG
    Am J Surg Pathol; 2018 Dec; 42(12):1647-1652. PubMed ID: 30222603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease.
    Kansal R; Nathwani BN; Yiakoumis X; Moschogiannis M; Sachanas S; Stefanaki K; Pangalis GA
    Hum Pathol; 2015 Jul; 46(7):1057-61. PubMed ID: 25953658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological findings in human autoimmune lymphoproliferative syndrome.
    Lim MS; Straus SE; Dale JK; Fleisher TA; Stetler-Stevenson M; Strober W; Sneller MC; Puck JM; Lenardo MJ; Elenitoba-Johnson KS; Lin AY; Raffeld M; Jaffe ES
    Am J Pathol; 1998 Nov; 153(5):1541-50. PubMed ID: 9811346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric features of incidental indolent T lymphoblastic proliferations.
    Fromm JR; Edlefsen KL; Cherian S; Wood BL; Soma L; Wu D
    Cytometry B Clin Cytom; 2020 May; 98(3):282-287. PubMed ID: 31571375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indolent T-lymphoblastic proliferation: a report of three cases.
    Yuanyuan Z; Jianlan X; Yanlin Z; Xiaoge Z
    Virchows Arch; 2022 May; 480(5):1121-1126. PubMed ID: 34482472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
    Brar N; Butzmann A; Kumar J; Peerani R; Morgan EA; Grigoriadis G; Kumar B; Tatarczuch RM; Warnke RA; Ohgami RS
    Histopathology; 2020 Dec; 77(6):984-988. PubMed ID: 32526041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow.
    Wang X; Ng CS; Chen C; Yu G; Yin W
    Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
    Khogeer H; Rahman H; Jain N; Angelova EA; Yang H; Quesada A; Ok CY; Sui D; Wei P; Al Fattani A; Pierce S; Loghavi S; Lamb A; Hu P; Thakral B; Kanagal-Shamanna R; Jorgensen JL; Jabbour EJ; Kantarjian HM; Medeiros LJ; Khoury JD
    Br J Haematol; 2019 Aug; 186(4):538-548. PubMed ID: 31115909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composite cutaneous T-cell lymphoma and small B-cell lymphocytic lymphoma: morphologic, immunologic, and molecular genetic documentation of concurrent lymph node involvement.
    Liu YC; Tomashefski JF; Cleveland RP; Nassar SJ; Trey JE
    Mod Pathol; 1994 Aug; 7(6):641-6. PubMed ID: 7991522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma.
    Ohgami RS; Zhao S; Ohgami JK; Leavitt MO; Zehnder JL; West RB; Arber DA; Natkunam Y; Warnke RA
    Am J Surg Pathol; 2012 Nov; 36(11):1619-28. PubMed ID: 23060347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric assessment of T-cell chronic lymphoproliferative disorders.
    Cady FM; Morice WG
    Clin Lab Med; 2007 Sep; 27(3):513-32, vi. PubMed ID: 17658405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
    Klobusická M; Babusíková O
    Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical importance of myeloid antigen expression in Moroccan patients with adult B-lineage acute lymphoblastic leukemia.
    Lahjouji A; Bachir F; Bennani S; Benchekroun S; E SA
    Neoplasma; 2013; 60(5):553-60. PubMed ID: 23790175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
    Moroch J; Copie-Bergman C; de Leval L; Plonquet A; Martin-Garcia N; Delfau-Larue MH; Molinier-Frenkel V; Belhadj K; Haioun C; Audouin J; Swerdlow SH; Marafioti T; Gaulard P
    Am J Surg Pathol; 2012 Nov; 36(11):1636-46. PubMed ID: 23073322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.